Degradation kinetics and mechanism of RH1, a new anti-tumor agent: a technical note.
Jain
Neera
N
Wyeth Research, Pearl River, NY 10965, USA.
Machatha
Stephen G
SG
Tabibi
S Esmail
SE
Yalkowsky
Samuel H
SH
D020341:Absorbable Implants; D000970:Antineoplastic Agents / Q000737:chemistry / Q000528:radiation effects; D000975:Antioxidants; D001388:Aziridines / Q000737:chemistry* / Q000528:radiation effects; D016227:Benzoquinones / Q000737:chemistry* / Q000528:radiation effects; D004339:Drug Compounding / Q000379:methods*; D004353:Drug Evaluation, Preclinical; D004355:Drug Stability; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008027:Light; D008422:Materials Testing; D012995:Solubility; D044366:Transition Temperature; D014867:Water / Q000737:chemistry*
C117776:2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone; D000970:Antineoplastic Agents; D000975:Antioxidants; D001388:Aziridines; D016227:Benzoquinones; D014867:Water